科研之友
微信
新浪微博
Facebook
分享链接
摘要
The prevalence of atrial fibrillation is much greater among persons with end-stage renal disease (ESRD) than among the general population. While significant advances have been made recently in the treatment of atrial fibrillation in the general population, we know very little about the treatment of atrial fibrillation among those with ESRD. This Commentary explores gaps in our knowledge of how to treat this vulnerable and sick population. Kidney International (2012) 81, 432-433. doi:10.1038/ki.2011.430
- 出版日期2012-3
